Welcome to LookChem.com Sign In|Join Free
  • or
benzyl (1s,3s)-3-((methylsulfonyl)oxy)cyclobutane-1-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

929913-27-9

Post Buying Request

929913-27-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

929913-27-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 929913-27-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,9,1 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 929913-27:
(8*9)+(7*2)+(6*9)+(5*9)+(4*1)+(3*3)+(2*2)+(1*7)=209
209 % 10 = 9
So 929913-27-9 is a valid CAS Registry Number.

929913-27-9Downstream Products

929913-27-9Relevant academic research and scientific papers

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

-

Page/Page column 277-278, (2020/01/24)

The present invention is directed towards compounds having the Formula (lb) or the Formulae (III) and pharmaceutically acceptable salts, solvates and clathrates thereof, compositions thereof, as well as towards the use of said compounds in methods for the treatment of a condition associated with a dysfunction in proteostasis.

NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE

-

Paragraph 0475; 0476, (2015/05/26)

The present invention embodiments relate to compound of Formula I or pharmaceutically acceptable enantiomers, salts or solvates thereof. The invention further relates in certain embodiments to the use of the compounds of Formula I as TDO2 inhibitors. The invention also relates in certain embodiments to the use of the compounds of Formula I for the treatment and/or prevention of cancer, neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression, and obesity. The invention also relates in certain embodiments to a process for manufacturing compounds of Formula I.

SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF

-

Page/Page column 401; 429, (2014/09/29)

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

OXINDOLE DERIVATIVE AS FEEDING CONTROL AGENT

-

Page/Page column 23-24, (2008/12/06)

Disclosed is a compound represented by the formula (1) below, a prodrug thereof or a pharmaceutically acceptable salt of either, which is useful as a therapeutic, preventive or ameliorating agent for diabetes and the like. (In the formula, R3 represents an optionally substituted carbamoyl group or the like; X represents a hydroxyl group or the like; W1 and W2 independently represent a single bond or methylene; R7 and R8 independently represent a hydrogen atom, an optionally substituted alkyl group or the like; and Ar represents an optionally substituted aryl group or the like.)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 929913-27-9